ArticleNeuro-oncology2019

Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.

Franziska Maria Ippen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.